Pharmacology, Toxicology and Pharmaceutical Science
Circulating microRNA
50%
Cardiovascular Disease
50%
Metabolic Syndrome X
50%
microRNA
50%
Non Insulin Dependent Diabetes Mellitus
50%
microRNA 122
50%
Atorvastatin
12%
Experimental Endotoxemia
12%
Heart Disease
7%
Vascular Disease
7%
Biological Marker
7%
Clinical Trial
7%
Antagomir
6%
Complement Factor H
6%
Insulin Resistance
6%
Plasma Protein
6%
Glycoprotein
6%
Very Low Density Lipoprotein
6%
Saturated Fatty Acid
6%
Monounsaturated Fatty Acid
6%
Apolipoprotein
6%
Medicine and Dentistry
microRNA
100%
Cardiovascular Disease
50%
Bariatric Surgery
34%
Adipose Tissue
10%
Chitinase
10%
Biological Marker
7%
Clinical Trial
7%
Heart Disease
7%
Cardiovascular System
7%
Human Genome
7%
Vascular Disease
7%
Gene Expression
7%
Experimental Endotoxemia
7%
Circulating microRNA
5%
microRNA 122
5%
Maturity Onset Diabetes of the Young
5%
Biochemical Process
5%
microRNA 221
5%
microRNA 192
5%
Body Mass Index
5%
microRNA 222
5%
White Adipose Tissue
5%
Transaminase
5%
Blood Glucose
5%
Mediator
5%
Metabolic Disorder
5%
Biochemistry, Genetics and Molecular Biology
MicroRNA
50%
Lipid
12%
Atorvastatin
12%
S100 Calcium Binding Protein A8
10%
Aggrecanase
8%
Afamin
6%
Saturated Fatty Acids
6%
Lipid Metabolism
6%
Lipid Profile
6%
Monounsaturated Fatty Acid
6%
Hepatocyte
6%
Glycoprotein
6%
Insulin Resistance
6%
Proteomics
6%
Apolipoprotein
6%
Serum Total Protein
6%
Lipid Liver Level
6%
Factor H
6%
Antagomir
6%
Mass Spectrometry
6%
Lipid Homeostasis
6%
